Antitumor effects of flavopiridol, a cyclin-dependent kinase inhibitor, on human cholangiocarcinoma in vitro and in an in vivo xenograft model

Flavopiridol, a pan-cyclin-dependent kinase (CDK) inhibitor, was recently identified as an effective antitumor agent for several cancers. We investigated the antitumor effect of flavopiridol on cholangiocarcinoma (CCA), in vitro and in vivo. A methylthiotetrazole assay revealed that the proliferatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Saisomboon, Saowaluk, Kariya, Ryusho, Vaeteewoottacharn, Kulthida, Wongkham, Sopit, Sawanyawisuth, Kanlayanee, Okada, Seiji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6515137/
https://www.ncbi.nlm.nih.gov/pubmed/31193061
http://dx.doi.org/10.1016/j.heliyon.2019.e01675

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6515137/
https://www.ncbi.nlm.nih.gov/pubmed/31193061
http://dx.doi.org/10.1016/j.heliyon.2019.e01675

Ejemplares similares